Smith & Nephew

Update in progress

SNN (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Smith & Nephew plc and its subsidiaries develop, manufacture, market, and sell medical devices and services worldwide. The company operates in three segments: Orthopaedics; Sports Medicine & ENT; and Advanced Wound Management. It offers knee and hip implants, trauma and extremities devices, and other reconstruction products; sports medicine instruments and implants; arthroscopy and visualization tools; ENT solutions; and advanced wound care and regenerative products and devices. Founded in 1856, based in Watford, UK.

Company score

Sentiment: 0.46; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.16; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.28; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.06; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.12; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.29; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive